Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

674
FinTech in Focus—May 23: Global Conference FinTech Recap article
FinTech in Focus—May 23: Global Conference FinTech Recap
In This Newsletter The FinTech Movement: Social Economic Mobility Strategies Moving Digital Assets
Forward | Part 1: A Conversation with Rostin Behnam
May 23, 2023
The American Dream Monthly — May 24, 2023 article
The American Dream Monthly — May 24, 2023
In This Newsletter MCAAD at Global Conference What We're Reading Building the Dream
May 24, 2023
National Institutes of Health (NIH) Director Nomination article
National Institutes of Health (NIH) Director Nomination
Esther Krofah Executive Vice President, Health Executive Director, FasterCures and Center for Public
Health   Milken Institute
May 15, 2023
Statement at Multi-Stakeholder meeting in support of the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response article
Statement at Multi-Stakeholder meeting in support of the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response
FasterCures would like to express our strong support for current initiatives to advance pandemic pre
vention, preparedness, and response. We appreciate the opportunity to provide our perspective in these critical discussions.
May 9, 2023
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006 article
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006
Submitted electronically Joni Rutter, Ph.D. National Center for Advancing Translational Sciences Na
tional Institutes of Health 6701 Democracy Blvd Bethesda, MD 20892-4874 Dear Director Rutter,
May 12, 2023
For the Third Consecutive Year Provo-Orem, Utah, Tops Milken Institute’s 2023 Ranking of Best-Performing Cities article
For the Third Consecutive Year Provo-Orem, Utah, Tops Milken Institute’s 2023 Ranking of Best-Performing Cities
May 16, 2023 (Los Angeles, CA) - Provo-Orem, Utah, for the 3rd consecutive year, has demonstrated th
e best performance among large cities, according to the 2023 Milken Institute Best-Performing Cities Index.
May 16, 2023
The Milken Institute, Motsepe Foundation Announce Winners of the Milken-Motsepe Prize in Agritech article
The Milken Institute, Motsepe Foundation Announce Winners of the Milken-Motsepe Prize in Agritech
LOS ANGELES AND JOHANNESBURG (May 1, 2023) — Today, the Milken Institute and the Motsepe F
oundation today announced
May 1, 2023
FinTech in Focus — May 3, 2021 article
FinTech in Focus — May 3, 2021
In this FinTech in Focus Industry Developments» Legislative Developments»   International De
velopments»  
Apr 30, 2021
Center for Strategic Philanthropy: Spring 2021 Newsletter article
Center for Strategic Philanthropy: Spring 2021 Newsletter
In This Newsletter Reports and Resources Tools for Philanthropists CSP and Partners in the News
Apr 28, 2021
Milken Institute and Motsepe Foundation Launch Technology Prize Program to Propel Innovation and Entrepreneurship in Africa article
Milken Institute and Motsepe Foundation Launch Technology Prize Program to Propel Innovation and Entrepreneurship in Africa
Registration is Open for $2 Million AgriTech Prize
Apr 28, 2021
Leveraging private capital is imperative to achieve the UN SDGs and improve health outcomes article
Leveraging private capital is imperative to achieve the UN SDGs and improve health outcomes
New report identifies ways NGOs can tap into private markets to support developing countries
Apr 19, 2021
Easing the Burdens of Rare Disease: Accelerating Diagnosis article
Easing the Burdens of Rare Disease: Accelerating Diagnosis
One in 10 people in the United States has a rare disease. Although tremendous progress has been made
to identify and understand the 7,000 known rare diseases, more than 95 percent of rare diseases still have no FDA-approved treatment.
Apr 20, 2021